131I-Anti CD20 Radioimmunotherapy of Relapsed or Refractory Non-Hodgkins Lymphoma: A Phase II Clinical Trial of a Nonmyeloablative Dose Regimen of Chimeric Rituximab Radiolabeled in a Hospital.

Autor:	J. Harvey Turner, Andrew A. Martindale, Jan Boucek, Phillip G. Claringbold, Michael F. Leahy
Zdroj:	Cancer Biotherapy & Radiopharmaceuticals; Aug2003, Vol. 18 Issue 4, p513, 12p
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu